PCA3 and prostate carcinoma: Patients with prostate cancer were found to have increased expression of the lncRNA PCA3 in sEVs obtained from their urine; therefore, PCA3 in urine-derived sEVs can be used as a marker for the early diagnosis of PCa [95].